ADA and breast carcinoma: An association between the activity of ADA2 in the plasma of patients with breast cancer with a pro-tumor M2 phenotype of macrophages, as well as the activity of ADA1, and endothelial cell dysfunction or inflammatory parameters [102] was shown.